Ergot compounds and brain function: neuroendocrine and neuropsychiatric aspects
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
New York
Raven Press
1980
|
| Schriftenreihe: | Advances in biochemical psychopharmacology
23 |
| Schlagworte: | |
| Beschreibung: | XVIII, 413 S. Ill., zahlr. graph. Darst. |
| ISBN: | 0890044503 |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV007545986 | ||
| 003 | DE-604 | ||
| 005 | 20141201 | ||
| 007 | t | ||
| 008 | 930421s1980 ad|| |||| 10||| eng d | ||
| 020 | |a 0890044503 |9 0-89004-450-3 | ||
| 035 | |a (OCoLC)5990252 | ||
| 035 | |a (DE-599)BVBBV007545986 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 |a DE-355 |a DE-91 |a DE-188 |a DE-578 |a DE-19 | ||
| 050 | 0 | |a RM315 | |
| 082 | 0 | |a 615/.78 | |
| 084 | |a XI 5400 |0 (DE-625)153014:12905 |2 rvk | ||
| 245 | 1 | 0 | |a Ergot compounds and brain function |b neuroendocrine and neuropsychiatric aspects |c ed. Menek Goldstein ... |
| 264 | 1 | |a New York |b Raven Press |c 1980 | |
| 300 | |a XVIII, 413 S. |b Ill., zahlr. graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Advances in biochemical psychopharmacology |v 23 | |
| 650 | 4 | |a Cerveau, Effets des médicaments sur le - Congrès | |
| 650 | 4 | |a Ergot - Effets physiologiques - Congrès | |
| 650 | 4 | |a Ergot - Emploi en thérapeutique - Congrès | |
| 650 | 4 | |a Neuroendocrinologie - Congrès | |
| 650 | 4 | |a Neuropsychiatrie - Congrès | |
| 650 | 4 | |a Neuropsychopharmacologie - Congrès | |
| 650 | 4 | |a Brain |x Effect of drug on |v Congresses | |
| 650 | 4 | |a Endocrine System Diseases |x drug therapy |v Congresses | |
| 650 | 4 | |a Ergot Alkaloids |x pharmacology |v Congresses | |
| 650 | 4 | |a Ergot Alkaloids |x therapeutic use |v Congresses | |
| 650 | 4 | |a Ergot alkaloids |x Physiological effect |v Congresses | |
| 650 | 4 | |a Ergot alkaloids |x Therapeutic use |v Congresses | |
| 650 | 4 | |a Ergot |x Physiological effect |v Congresses | |
| 650 | 4 | |a Ergot |x Therapeutic use |v Congresses | |
| 650 | 4 | |a Nervous System Diseases |x drug therapy |v Congresses | |
| 650 | 4 | |a Neuroendocrinology |v Congresses | |
| 650 | 4 | |a Neuropsychiatry |v Congresses | |
| 650 | 4 | |a Neuropsychopharmacology |v Congresses | |
| 650 | 0 | 7 | |a Ergotalkaloide |0 (DE-588)4152760-4 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmakologie |0 (DE-588)4045687-0 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
| 689 | 0 | 0 | |a Ergotalkaloide |0 (DE-588)4152760-4 |D s |
| 689 | 0 | 1 | |a Pharmakologie |0 (DE-588)4045687-0 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Goldstein, Menek |e Sonstige |4 oth | |
| 830 | 0 | |a Advances in biochemical psychopharmacology |v 23 |w (DE-604)BV036809028 |9 23 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-004918045 | ||
| 980 | 4 | |a (DE-12)AK4400907 | |
| 980 | 4 | |a (DE-12)AK08270380 | |
Datensatz im Suchindex
| _version_ | 1804121843861291008 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV007545986 |
| callnumber-first | R - Medicine |
| callnumber-label | RM315 |
| callnumber-raw | RM315 |
| callnumber-search | RM315 |
| callnumber-sort | RM 3315 |
| callnumber-subject | RM - Therapeutics and Pharmacology |
| classification_rvk | XI 5400 |
| ctrlnum | (OCoLC)5990252 (DE-599)BVBBV007545986 |
| dewey-full | 615/.78 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615/.78 |
| dewey-search | 615/.78 |
| dewey-sort | 3615 278 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02455nam a2200625 cb4500</leader><controlfield tag="001">BV007545986</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20141201 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">930421s1980 ad|| |||| 10||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0890044503</subfield><subfield code="9">0-89004-450-3</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)5990252</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV007545986</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-91</subfield><subfield code="a">DE-188</subfield><subfield code="a">DE-578</subfield><subfield code="a">DE-19</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM315</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.78</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XI 5400</subfield><subfield code="0">(DE-625)153014:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Ergot compounds and brain function</subfield><subfield code="b">neuroendocrine and neuropsychiatric aspects</subfield><subfield code="c">ed. Menek Goldstein ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York</subfield><subfield code="b">Raven Press</subfield><subfield code="c">1980</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XVIII, 413 S.</subfield><subfield code="b">Ill., zahlr. graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Advances in biochemical psychopharmacology</subfield><subfield code="v">23</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cerveau, Effets des médicaments sur le - Congrès</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ergot - Effets physiologiques - Congrès</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ergot - Emploi en thérapeutique - Congrès</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neuroendocrinologie - Congrès</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neuropsychiatrie - Congrès</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neuropsychopharmacologie - Congrès</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Brain</subfield><subfield code="x">Effect of drug on</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Endocrine System Diseases</subfield><subfield code="x">drug therapy</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ergot Alkaloids</subfield><subfield code="x">pharmacology</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ergot Alkaloids</subfield><subfield code="x">therapeutic use</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ergot alkaloids</subfield><subfield code="x">Physiological effect</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ergot alkaloids</subfield><subfield code="x">Therapeutic use</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ergot</subfield><subfield code="x">Physiological effect</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ergot</subfield><subfield code="x">Therapeutic use</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nervous System Diseases</subfield><subfield code="x">drug therapy</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neuroendocrinology</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neuropsychiatry</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neuropsychopharmacology</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Ergotalkaloide</subfield><subfield code="0">(DE-588)4152760-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakologie</subfield><subfield code="0">(DE-588)4045687-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Ergotalkaloide</subfield><subfield code="0">(DE-588)4152760-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Pharmakologie</subfield><subfield code="0">(DE-588)4045687-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Goldstein, Menek</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Advances in biochemical psychopharmacology</subfield><subfield code="v">23</subfield><subfield code="w">(DE-604)BV036809028</subfield><subfield code="9">23</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-004918045</subfield></datafield><datafield tag="980" ind1="4" ind2=" "><subfield code="a">(DE-12)AK4400907</subfield></datafield><datafield tag="980" ind1="4" ind2=" "><subfield code="a">(DE-12)AK08270380</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift gnd-content |
| genre_facet | Konferenzschrift |
| id | DE-604.BV007545986 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T17:04:26Z |
| institution | BVB |
| isbn | 0890044503 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-004918045 |
| oclc_num | 5990252 |
| open_access_boolean | |
| owner | DE-12 DE-355 DE-BY-UBR DE-91 DE-BY-TUM DE-188 DE-578 DE-19 DE-BY-UBM |
| owner_facet | DE-12 DE-355 DE-BY-UBR DE-91 DE-BY-TUM DE-188 DE-578 DE-19 DE-BY-UBM |
| physical | XVIII, 413 S. Ill., zahlr. graph. Darst. |
| publishDate | 1980 |
| publishDateSearch | 1980 |
| publishDateSort | 1980 |
| publisher | Raven Press |
| record_format | marc |
| series | Advances in biochemical psychopharmacology |
| series2 | Advances in biochemical psychopharmacology |
| spelling | Ergot compounds and brain function neuroendocrine and neuropsychiatric aspects ed. Menek Goldstein ... New York Raven Press 1980 XVIII, 413 S. Ill., zahlr. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Advances in biochemical psychopharmacology 23 Cerveau, Effets des médicaments sur le - Congrès Ergot - Effets physiologiques - Congrès Ergot - Emploi en thérapeutique - Congrès Neuroendocrinologie - Congrès Neuropsychiatrie - Congrès Neuropsychopharmacologie - Congrès Brain Effect of drug on Congresses Endocrine System Diseases drug therapy Congresses Ergot Alkaloids pharmacology Congresses Ergot Alkaloids therapeutic use Congresses Ergot alkaloids Physiological effect Congresses Ergot alkaloids Therapeutic use Congresses Ergot Physiological effect Congresses Ergot Therapeutic use Congresses Nervous System Diseases drug therapy Congresses Neuroendocrinology Congresses Neuropsychiatry Congresses Neuropsychopharmacology Congresses Ergotalkaloide (DE-588)4152760-4 gnd rswk-swf Pharmakologie (DE-588)4045687-0 gnd rswk-swf (DE-588)1071861417 Konferenzschrift gnd-content Ergotalkaloide (DE-588)4152760-4 s Pharmakologie (DE-588)4045687-0 s DE-604 Goldstein, Menek Sonstige oth Advances in biochemical psychopharmacology 23 (DE-604)BV036809028 23 |
| spellingShingle | Ergot compounds and brain function neuroendocrine and neuropsychiatric aspects Advances in biochemical psychopharmacology Cerveau, Effets des médicaments sur le - Congrès Ergot - Effets physiologiques - Congrès Ergot - Emploi en thérapeutique - Congrès Neuroendocrinologie - Congrès Neuropsychiatrie - Congrès Neuropsychopharmacologie - Congrès Brain Effect of drug on Congresses Endocrine System Diseases drug therapy Congresses Ergot Alkaloids pharmacology Congresses Ergot Alkaloids therapeutic use Congresses Ergot alkaloids Physiological effect Congresses Ergot alkaloids Therapeutic use Congresses Ergot Physiological effect Congresses Ergot Therapeutic use Congresses Nervous System Diseases drug therapy Congresses Neuroendocrinology Congresses Neuropsychiatry Congresses Neuropsychopharmacology Congresses Ergotalkaloide (DE-588)4152760-4 gnd Pharmakologie (DE-588)4045687-0 gnd |
| subject_GND | (DE-588)4152760-4 (DE-588)4045687-0 (DE-588)1071861417 |
| title | Ergot compounds and brain function neuroendocrine and neuropsychiatric aspects |
| title_auth | Ergot compounds and brain function neuroendocrine and neuropsychiatric aspects |
| title_exact_search | Ergot compounds and brain function neuroendocrine and neuropsychiatric aspects |
| title_full | Ergot compounds and brain function neuroendocrine and neuropsychiatric aspects ed. Menek Goldstein ... |
| title_fullStr | Ergot compounds and brain function neuroendocrine and neuropsychiatric aspects ed. Menek Goldstein ... |
| title_full_unstemmed | Ergot compounds and brain function neuroendocrine and neuropsychiatric aspects ed. Menek Goldstein ... |
| title_short | Ergot compounds and brain function |
| title_sort | ergot compounds and brain function neuroendocrine and neuropsychiatric aspects |
| title_sub | neuroendocrine and neuropsychiatric aspects |
| topic | Cerveau, Effets des médicaments sur le - Congrès Ergot - Effets physiologiques - Congrès Ergot - Emploi en thérapeutique - Congrès Neuroendocrinologie - Congrès Neuropsychiatrie - Congrès Neuropsychopharmacologie - Congrès Brain Effect of drug on Congresses Endocrine System Diseases drug therapy Congresses Ergot Alkaloids pharmacology Congresses Ergot Alkaloids therapeutic use Congresses Ergot alkaloids Physiological effect Congresses Ergot alkaloids Therapeutic use Congresses Ergot Physiological effect Congresses Ergot Therapeutic use Congresses Nervous System Diseases drug therapy Congresses Neuroendocrinology Congresses Neuropsychiatry Congresses Neuropsychopharmacology Congresses Ergotalkaloide (DE-588)4152760-4 gnd Pharmakologie (DE-588)4045687-0 gnd |
| topic_facet | Cerveau, Effets des médicaments sur le - Congrès Ergot - Effets physiologiques - Congrès Ergot - Emploi en thérapeutique - Congrès Neuroendocrinologie - Congrès Neuropsychiatrie - Congrès Neuropsychopharmacologie - Congrès Brain Effect of drug on Congresses Endocrine System Diseases drug therapy Congresses Ergot Alkaloids pharmacology Congresses Ergot Alkaloids therapeutic use Congresses Ergot alkaloids Physiological effect Congresses Ergot alkaloids Therapeutic use Congresses Ergot Physiological effect Congresses Ergot Therapeutic use Congresses Nervous System Diseases drug therapy Congresses Neuroendocrinology Congresses Neuropsychiatry Congresses Neuropsychopharmacology Congresses Ergotalkaloide Pharmakologie Konferenzschrift |
| volume_link | (DE-604)BV036809028 |
| work_keys_str_mv | AT goldsteinmenek ergotcompoundsandbrainfunctionneuroendocrineandneuropsychiatricaspects |